News AbbVie waits on data from Humira successor Ablynx's vobarilizumab seen as key should Humira sales fall.
News US regulatory advisers to review Amgen's Humira biosimilar World's biggest selling drug could face competition.
News Biosimilar switching not suitable for all patients Antibodies against originator will also target biosimilar.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
